Immunophenotyping of one hundred and eighty-eight samples from AML-type M2 patients showed CD19 expression in 29.6% of cases, while in another study, five out of seventy-nine AML pediatric samples showed CD19+ expression when assessed by flow cytometry [22,23]. Here, CD19 is linked to acute myeloid leukemia.